PomDoctor Limited (POM)
| Market Cap | 592.22M |
| Revenue (ttm) | 45.02M |
| Net Income (ttm) | -18.99M |
| Shares Out | 118.44M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About AMPS
Pomdoctor is a leading online medical services platform for chronic diseases in China, ranking sixth on China’s Internet hospital market measured by the number of contracted doctors in 2022. With focuses on chronic disease management and pharmaceutical services, our business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. [Read more]
Financial Performance
Financial StatementsNews
PomDoctor Files For Nasdaq IPO That May Be Overvalued
The online health services provider aims to raise up to $30 million through a Nasdaq listing, even as its liabilities far outweigh its assets
PomDoctor Begins $15 Million U.S. IPO Rollout
PomDoctor Limited is raising $15 million in an IPO to expand its telehealth platform in China. The telehealth sector is expected to grow substantially in the coming year in China. However, POM faces i...
Chinese online medical platform PomDoctor files for a $15 million US IPO
PomDoctor, an online platform in China offering chronic disease management services, filed on Thursday with the SEC to raise up to $15 million in an initial public offering.
Pomdoctor IPO Registration Document (F-1)
Pomdoctor has filed to go public with an IPO on the NASDAQ.